Featured Research

from universities, journals, and other organizations

Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study

Date:
January 29, 2014
Source:
Oslo University Hospital
Summary:
Combination of radiotherapy and hormone treatment more than halves mortality rates for prostate cancer, reports a new article.

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

Related Articles


The figures were presented by Norwegian cancer researcher Sophie Fosså at an international conference sponsored by the American Society of Clinical Oncology (ASCO) in San Francisco this week.

By adding radiotherapy to the standard hormone treatment against prostate cancer, the 10 to 15 year survival rate for men with prostate cancer more than doubled, according to a long term follow-up study where Dr. Sophie Fosså is lead author. She is a professor at Oslo University Hospital in Norway.

Behind the study are Dr. Fosså and researchers from The Scandinavian Prostate Cancer Group. "When this study started in 1996, the standard treatment was hormone therapy alone, but this trial continues to show that adding radiotherapy substantially boosts long-term survival," says Dr. Fosså.

"This combination more than doubles the 10-year survival rate and confirms that this approach should be a standard option for men with this type of prostate cancer who are expected to live at least another 10 years."

In all, 875 male patients from Norway, Sweden and Denmark participated in the study. Of these, 653 participants were Norwegians.

  • Among the 439 men who underwent hormone therapy alone, 118 died of prostate cancer.
  • Among the 436 who underwent the combination treatment, 45 died of cancer.
  • Among the patients that underwent hormone therapy only, the 10 and 15 year mortality rates were 18.9 percent and 30.7 percent, respectively.
  • Among those that underwent the combination treatment, the figures amounted to 8.3 percent and 12.4 percent, respectively.

The figures presented by Dr. Fosså at the ASCO conference are a follow-up to an earlier study published in The Lancet in 2009, where Fosså and her colleagues demonstrate how radiotherapy in combination with hormone treatment reduced prostate cancer mortality from 24 to 12 percent.


Story Source:

The above story is based on materials provided by Oslo University Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Anders Widmark, Olbjørn Klepp, Arne Solberg, Jan-Erik Damber, Anders Angelsen, Per Fransson, Jo-Åsmund Lund, Ilker Tasdemir, Morten Hoyer, Fredrik Wiklund, Sophie D Fosså. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. The Lancet, 2009; 373 (9660): 301 DOI: 10.1016/S0140-6736(08)61815-2

Cite This Page:

Oslo University Hospital. "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." ScienceDaily. ScienceDaily, 29 January 2014. <www.sciencedaily.com/releases/2014/01/140129134909.htm>.
Oslo University Hospital. (2014, January 29). Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2014/01/140129134909.htm
Oslo University Hospital. "Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study." ScienceDaily. www.sciencedaily.com/releases/2014/01/140129134909.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) — Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) — Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Raw: Paralyzed Marine Walks With Robotic Braces

Raw: Paralyzed Marine Walks With Robotic Braces

AP (Nov. 21, 2014) — Marine Corps officials say a special operations officer left paralyzed by a sniper's bullet in Afghanistan walked using robotic leg braces in a ceremony to award him a Bronze Star. (Nov. 21) Video provided by AP
Powered by NewsLook.com
Milestone Birthdays Can Bring Existential Crisis, Study Says

Milestone Birthdays Can Bring Existential Crisis, Study Says

Newsy (Nov. 21, 2014) — Researchers find that as people approach new decades in their lives they make bigger life decisions. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins